Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP977396.RAd8MWHzUIz8P9nGHSrzHWKUw7xJxZJ2m2UnRuWPJrnAY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP977396.RAd8MWHzUIz8P9nGHSrzHWKUw7xJxZJ2m2UnRuWPJrnAY130_assertion type Assertion NP977396.RAd8MWHzUIz8P9nGHSrzHWKUw7xJxZJ2m2UnRuWPJrnAY130_head.
- NP977396.RAd8MWHzUIz8P9nGHSrzHWKUw7xJxZJ2m2UnRuWPJrnAY130_assertion description "[Currently, a humanized anti-4-1BB is in clinical trials in patients with solid tumors, including melanoma, renal carcinoma, and ovarian cancer, and so far seems to have a favorable toxicity profile.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977396.RAd8MWHzUIz8P9nGHSrzHWKUw7xJxZJ2m2UnRuWPJrnAY130_provenance.
- NP977396.RAd8MWHzUIz8P9nGHSrzHWKUw7xJxZJ2m2UnRuWPJrnAY130_assertion evidence source_evidence_literature NP977396.RAd8MWHzUIz8P9nGHSrzHWKUw7xJxZJ2m2UnRuWPJrnAY130_provenance.
- NP977396.RAd8MWHzUIz8P9nGHSrzHWKUw7xJxZJ2m2UnRuWPJrnAY130_assertion SIO_000772 22532596 NP977396.RAd8MWHzUIz8P9nGHSrzHWKUw7xJxZJ2m2UnRuWPJrnAY130_provenance.
- NP977396.RAd8MWHzUIz8P9nGHSrzHWKUw7xJxZJ2m2UnRuWPJrnAY130_assertion wasDerivedFrom befree-2016 NP977396.RAd8MWHzUIz8P9nGHSrzHWKUw7xJxZJ2m2UnRuWPJrnAY130_provenance.
- NP977396.RAd8MWHzUIz8P9nGHSrzHWKUw7xJxZJ2m2UnRuWPJrnAY130_assertion wasGeneratedBy ECO_0000203 NP977396.RAd8MWHzUIz8P9nGHSrzHWKUw7xJxZJ2m2UnRuWPJrnAY130_provenance.